Current Evidence for Oral Micronutrient Therapy in AMD With Drs. Rishi Singh and Lejla Vajzovic

You are now listening to MedEdTalks, a Vindico Medical Education production.

This podcast is eligible for CE credit.

For details, please view the episode notes or CE information.

Now, here's your host.

Hello, I'm Dr. Rishi Singh, Chair of Ophthalmology at Mass Eye and Ear, Mass General Brigham and Boston, Massachusetts, and I'm your host for today's program.

This is a continuing medical education activity provided by Vindico Medical Education and is supported by an educational grant from Bausch & Lomb.

I'm pleased to welcome my colleague and friend, Dr. Leila Vacevic, professor of ophthalmology and director of the Duke Surgical Vitretinal Fellowship Program and co-director of the Duke Pediatric Retina and Optic Nerve Center at Duke University Eye Center.

Welcome, Leila.

Thank you.

Thank you, Rishi.

It's such a pleasure to be here with you.

So today you're listening to the Optimizing Oral Micronutrient Therapy in AMD, a series in which you explore clinical data and best practices for incorporating mineral and nutrient supplements into the care of patients with age-related macular degeneration.

In today's episode, we'll be focusing on the current evidence base for oral micronutrient therapy in AMD.

So let's begin.

You are now listening to MedEdTalks, a Vindico Medical Education production.

This podcast is eligible for CE credit.

For details, please view the episode notes or CE information.

Now, here's your host.

Hello, I'm Dr. Rishi Singh, Chair of Ophthalmology at Mass Eye and Ear, Mass General Brigham and Boston, Massachusetts, and I'm your host for today's program.

This is a continuing medical education activity provided by Vindico Medical Education and is supported by an educational grant from Bausch & Lomb.

I'm pleased to welcome my colleague and friend, Dr. Leila Vacevic, professor of ophthalmology and director of the Duke Surgical Vitretinal Fellowship Program and co-director of the Duke Pediatric Retina and Optic Nerve Center at Duke University Eye Center.

Welcome, Leila.

Thank you.

Thank you, Rishi.

It's such a pleasure to be here with you.

So today you're listening to the Optimizing Oral Micronutrient Therapy in AMD, a series in which you explore clinical data and best practices for incorporating mineral and nutrient supplements into the care of patients with age-related macular degeneration.

In today's episode, we'll be focusing on the current evidence base for oral micronutrient therapy in AMD.

So let's begin.